Oncology Biomarker Articles & Analysis
7 news found
To illustrate the capabilities of this pioneering technology, CD ComputaBio has already achieved notable successes in designing antibodies for a spectrum of challenging targets, including: 1. Oncology: Specific cancer biomarkers are targeted for more effective and less toxic treatments. 2. ...
PathPresenter, a pioneer in the development of digital pathology software, and 4D Path Inc., developer of a pan-cancer diagnostic and precision oncology platform enabling AI-based biomarker typing and prognostication from H&E images, are announcing today a global partnership to distribute 4D Q-plasia OncoReader Breast within PathPresenter’s new Clinical ...
OncoDNA, a genomic and theranostic company specializing in precision medicine, and Bergonié Institute, a non-profit private hospital entirely devoted to fighting cancer, today announced a new clinical trial to evaluate the use of comprehensive biomarker testing and liquid biopsy in 700 patients diagnosed with an advanced metastatic cancer. The Appolo study will recruit patients from 6 ...
4D Path, a company conceived by an experienced team of scientists, clinicians and management from leading research institutions including MIT, Harvard Medical School and the University of Cambridge, has unveiled a faster, more efficient approach to cancer diagnosis and biomarker profiling with better accuracy that accelerates and democratizes precision medicine for optimized ...
“In oncology we have shown a whole host of specific biomarkers and specific mechanisms of actions for drug-able targets,” says Jordan Clark, chief technical officer, Diaceutics, a data analytics and implementation services company. ...
Thermo Fisher Scientific, the world leader in serving science, will present a series of abstracts that will highlight exciting advances in clinical research with applications in immuno-oncology, tumor biology and biomarker discovery during the American Association for Cancer Research (AACR) 2018 Annual Meeting (booth #1805) in Chicago, April 14-18. ...
On Tuesday, March 4, Dako will co-host an Exhibitor Seminar in cooperation with one of its pharmaceutical partners, Bristol-Myers Squibb, titled "Exploring Immune-Based Biomarkers in Oncology," from 5:30-7:30 p.m. in Room 29D. This seminar will update the pathology community on the importance of emerging immune therapies for the treatment of cancer and the need ...